Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.56 USD | -2.24% | +1.26% | +34.12% |
04-19 | Lake Street Starts Cellebrite DI With Buy Rating, $13 Price Target | MT |
04-01 | BofA Securities Adjusts Cellebrite DI Price Target to $13 From $12, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.12% | 2.43B | |
+10.95% | 87.18B | |
+7.02% | 78.95B | |
-9.94% | 55.02B | |
+23.40% | 47.3B | |
+31.81% | 46.79B | |
-27.13% | 46.35B | |
+81.70% | 42.08B | |
-6.11% | 25.86B | |
+21.61% | 22.54B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Earnings Flash (CLBT) CELLEBRITE DI Posts Q4 Revenue $93M, vs. Street Est of $85.5M